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a  b  s  t  r  a  c  t
INTRODUCTION:  Gynecomastia  is  the  benign  proliferation  of  the  glandular  tissue  in  the  male  breast.  This
condition is  thought  to be  caused  by the  imbalance  between  estrogen  action  relative  to  androgen  action  at
the  breast  tissue  level.  Bilateral  gynecomastia  is  frequently  found  in  the  neonatal  period,  early  in  puberty,
and with  increasing  age.  Prepubertal  unilateral  gynecomastia  in  the  absence  of endocrine  abnormalities
is  extremely  rare, with  only  a few cases  in literature.
PRESENTATION  OF  CASE:  We  present  an  otherwise  healthy  boy  of 12 years  old  with  unilateral  breast
masses.  No  abnormalities  were  found  on  ultrasonography  and  on  all  endocrine  parameters.  Treatment
consisted  in  a  new  “modiﬁed”  Webster  technique.
DISCUSSION:  The  results  conﬁrmed  validity  of this  technique  in terms  of  esthetic  and  functional  results,
and  patient  satisfaction.  Atypical  presentations  of gynecomastia  are  often  not  recognized.  The  main
pathophysiology  of  gynecomastia  is alteration  in  the  balance  between  the  stimulatory  effect  of  estrogen
and  the  inhibitory  effects  of androgens  on the development  of  the  breast.  If  there  is  no  causal  treatment,
surgical  resection  is  the  therapy  of ﬁrst  choice.
CONCLUSION:  The  exact  mechanism  of  unilateral  gynecomastia  formation  in our case is  unclear.  The
evaluation  of  unilateral  gynecomastia  can  therefore  be complex.  In  conclusion,  the  surgical  treatment  of
unilateral  gynecomastia  requires  an  individual  approach,  based  on  an  appropriate  diagnostic  algorithm.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Gynecomastia is the benign proliferation of the glandular tissue
n the male breast. Gynecomastia may  cause considerable psycho-
ogical distress, anxiety, discomfort and fear of breast cancer, it is
lso commonly associated with breast pain, ranging in intensity,
rom mild tenderness or sensitivity to constant pain and ten-
ion [1]. This condition is thought to be caused by the imbalance
etween estrogen action relative to androgen action at the breast
issue level [2]. Elevated serum estrogen levels may  be a result
f estrogen-secreting neoplasms or their precursors (ex. Leydig
r Sertoli cell tumors, hCG-producing tumors and adrenocortical
umors) but are more commonly caused by increased extragonadal
onversion of androgens to estrogens by tissue aromatase. Lev-
ls of free serum testosterone are lower in patients with gonadal
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failure, which can be primary (Klinefelter syndrome, mumps  orchi-
tis) or secondary (hypothalamic and pituitary disease). Several
other medical conditions are associated with Gynecomastia such
as androgen resistance syndromes, hyperthyroidism, chronic liver
disease, use of certain medications such as spironolactone, digoxin,
bicalutamide, cimetidine and abuse of such drugs as alcohol and
marijuana [3]. While bilateral gynecomastia is common in the
neonatal period, early in puberty, and with increasing age, prepu-
bertal unilateral gynecomastia is a rare condition, with only a few
cases in literature [4]. We  report a clinical and surgical management
of a boy with prepubertal unilateral gynecomastia. In this article,
we describe the pathophysiology and introduce a diagnostic algo-
rithm to facilitate evaluation and management of this symptomatic
case.
2. Presentation of caseA 12-year-old boy presented with a 12-month history of left
breast enlargement. The patient also complained of tenderness
of the breast mass reporting major discomfort in everyday life.
Family history was  negative for breast malignancies, but positive
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Diagnostic algorithm for gynecomastia.
F  there are no solid nodular or cystic formations. (B) The testicular ultrasound scan showed


































Laboratory data of patient.
Range Patient I
Thyroid function
fT3 1.1–5.3 pg/mL 4.4
fT4  6.9–16.9 pg/mL 10.5
TSH 0.20–6.1 microUI/mL 4.94
Ab  anti-thyroglobulin Untill to 100 UI/mL 3.9
Ab  anti-thyroid-peroxidase Until to 30 UI/mL 3.6
Sexual hormones
LH 1–8.4 Ul/L 0.7
FSH  1–10.5 Ul/L 1.7
Estrone 30–90 pg/mL 19
Prolattina 2.3–11.5 ng/mL 5.2
17  beta estradiol Until to 36 pg/mL 3.2
Testosterone 5–78 ng/dL 23
Delta 4 androstenedione 1.2–3.5 ng/mL 0.9
17-OH progesterone 0.07–1.53 ng/mL 0.9
Cortisol 6.8–26.3 g/dL 11.5
Liver function
GOT/AST 5–42 UI/L 17
GTP/ALT 11–48 UI/L 22
Gamma-GT 8–61 U/L 13
Total bilirubin Until to 1.2 mg/dL 0.27
Direct bilirubin Until to 0.5 mg/dL 0.14
Kidney function
Azotemia 20–50 mg/dL 29
Creatinine 0.6–1.15 mg/dL 0.7
Uric acid 2.6–6 mg/dL 4.8
Na  135–146 Meq/L 132
K  3.50–5.30 Meq/L 4.1
Tumor markersig. 2. (A) The breast ultrasound scan showed monolateral gynecomastia. Moreover
ormal-sized organ. (C) The abdominal ultrasound scan showed normal-sized adr
rgan.
or prepubertal bilateral gynecomastia in a cousin then regressed.
aternal familiarity for unknown thyroid disease. Paternal grand-
other with breast cancer. 2-year-old sister died of meningitis
omplications. No drugs or dermal applications were used. Physi-
al examination showed a lively healthy-appearing boy. Inspection
as carried out with patient undressed from the waist upwards,
n a seated position, with arms relaxed, with arms raised and
ith hands pressed against the hips to contract pectoral mus-
les. The patient was 139.2 cm tall (3–10th, SDS −1.5) with no
ccelerated growth velocity (bone age 10 years), weight 41.3 kg
25–50th, SDS −0.3), BMI  of 21.3 (50–75th, SDS 0.5). The puber-
al stage was PH1 G1 and testicular volume of 3–4 mL.  Palpation
f the left breast revealed a ﬁrm mass, painful on deep palpation
ith hypertrophy of all structural components, nipple-areola com-
lex about 1 cm below the inframammary fold (Tanner stage III).
alpation of axillary nodes was performed were negative. No his-
ory or sign of galactorrhea or bleeding from nipple. Before surgery,
atient had undergone diagnostic evaluation including laboratory
nd radiographic tests with diagnostic algorithm to facilitate step-
y-step evaluation and correct surgical approach. Firstly, according
o our protocol (Fig. 1), evaluation of all endocrine parameters
as provided, including the thyroid function test (fT3, fT4, TSH,
nti-thyroglobulin, anti-thyroid-peroxidase) and sexual hormones
extradiol, FSH, LH, delta-4-androstenedione, 17-OH-progesterone,
strone, testosterone, prolactine); liver function tests; kidney func-
ion tests; tumor markers (alpha-fetoprotein, beta-HCG, Ca125).
ll parameters were found to be within normal limits (Table 1).
econdly, instrumental tests such as mammary ultrasonography
Fig. 2A), testicular ultrasonography (Fig. 2B) and upper and lower
bdomen ultrasonography (Fig. 2C) were performed. Ultrasound
xamination of bilateral breast showed normal representation of
Alpha-fetoprotein Until to 6 ng/mL 0.9
Beta-HCG Until to 10 mIU/mL 0.1
Ca125 Until to 37 g/mL 0.5
Age, years 12
CASE  REPORT  –  OPEN  ACCESS
1160 G.A. Ferraro et al. / International Journal of Surgery Case Reports 5 (2014) 1158–1161





































rig. 3. Clinical evidence for the use of mastectomy. (A) Preoperative frontal view.
ostoperative frontal view six months after surgery of patient I. (G,H) Postoperativ
urgery.
kin and subcutaneous tissue of the right breast. Tests revealed
eft breast hypertrophy with considerable increase of the glan-
ular component. No axillary lymph nodes. An abdominal and
esticular ultrasound scan excluded any estrogen-producing tumor.
urgery under general anesthesia consisted of radical subcutaneous
esection of the gland. A concentric circumareolar incision was
ade to include the epidermis that was then de-epithelized to
orrect skin redundancy. Subsequently a transdermal incision was
ade in the de-epithelized area and breast tissue was dissected
nder direct vision. The dissection of breast tissue was performed
rom the skin at the top and until to pectoral muscle at the bottom.
he breast tissue removed was sent to the pathologist. Hemosta-
is was carefully monitored and subsequent drainage suction was
nserted through a separate incision in the axillary region. The sur-
ical technique foresees leaving a 5–7 mm  pad under the nipple to
revent dermal adherence to the pectoralis fascia, but in this case,
he gland was totally removed and advancement ﬂap of adipose
issue was created to prevent the adhesion of the nipple to the pec-
oralis fascia and to avoid unesthetic depression. The “round block”
urse-string suture was performed to close the deep dermis with
 non-absorbable monoﬁlament stitch and the areola was closed
ith the surrounding epidermis by a running suture.
A compressive medication was applied after surgery with a chest
andage for 4 weeks. Analgesics were prescribed only if the boy
eported pain. Post-surgery examination included evaluation for
nset of hematomas, seromas, skin infections and pain.
Pathologic examination revealed normal glandular breast
issue, with no evidence of malignancy. Microscopy of the sub-
utaneous mastectomy specimen showed mammary ducts with
ypertrophic ductuli. The concluding diagnosis was ﬂorid gyneco-
astia (Table 2). Postoperative clinical and radiologic evaluation
evealed no signs of recent breast development, although proba-
ly the boy will undergo a possible additional surgical procedure
able 2
mmunohistochemical data of patient.
Results
Thyroid function
Estrogen receptor alpha Positivity






ER2: human EGF (epidermal growth factor) receptor 2. GPR30: G protein-coupled
eceptor. IGF-IR: insulin growth factor 1 receptor.Preoperative right lateral view. (D,E) Preoperative left lateral view of patient I. (F)
t lateral view 1 year after surgery. (I,J) Postoperative left lateral view 1 year after
of liposuction to shape deﬁnitively the contour respect to the
contralateral breast. After surgery, the boy were followed for an
additional year for evaluation of sex hormone levels (data not
shown), growth curve (data not shown) and breast size (Fig. 3).
3. Discussion
Gynecomastia is a benign enlargement of the male breast due
to the proliferation of the glandular component. Male breast tissue
proliferation can occur at all ages and may  be unilateral or bilateral.
Due to the feminization of the male breast, the patient may  develop
major physical problems and suffer negative social consequences.
The objective of plastic surgery therapy is to restore the pheno-
type male breast that would predict a fundamentally pre-operative
evaluation. Common causes for breast enlargement include hor-
monal defects, carcinoma, endocrine disease, systemic disorders
and implication of certain drugs [5]. The main pathophysiology
of gynecomastia is alteration in the balance between the stimu-
latory effect of estrogen and the inhibitory effects of androgens
on the development of the breast [6]. There are some studies on
sports-related unilateral gynecomastia due to the use of anabolic
steroids in body builders [7]. Our patient showed normal hormonal
status and no history of steroid use. Large epidemiologic studies
may  have revealed that there is no probable association between
the occurrence of gynecomastia and breast cancer [8]. However,
literature in histopathology reports identiﬁcation of malignant or
semi-malignant tumor after undergoing gynecomastia [9]. Our
patient was  asymptomatic and we exclude malignancy based on
the histopathologic diagnosis. However, the etiology of gyneco-
mastia is still understood to a limited, extent and up to 50% of
the cases may  have no obvious cause [10]. In this case, we decided
to proceed with surgery resolution of gynecomastia. A signiﬁcant
reduction of breast volume with glandular tissue removal and skin
retraction was achieved with an aspect of the chest very similar to
the male. We  have wrapped an advancement ﬂap of adipose tissue
below the nipple-areola complex because, for unknown etiology,
we could not leave residual subareolar glandular parenchyma. This
technique has allowed us to combine a good esthetic result, thus
avoiding the depression of the nipple-areola complex. In the litera-
ture, the surgical approach to the treatment of gynecomastia shows
a wide variation. Untimely publications focused on surgical exci-
sion of the glandular tissue such as Webster technique [11]. This
“semicircular intra-areolar incision” approach is ideal for mild and
moderate gynecomastia. While more recent studies advocate the
unique use of liposuction such as suction-assisted lipectomy tech-
nique or ultrasound-assisted liposuction [12]. The ﬁrst approach is
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deal for mostly fatty gynecomastia, whereas the second approach
s ideal for mostly ﬁbrous gynecomastia. These techniques, empha-
izing superior esthetic results, have the disadvantage of not take
ccount of possible disease (e.g., cancer) of the male breast. For
he high-grade gynecomastia, there are few approaches such as
astectomy with free nipple graft or subcutaneous mastectomy
nd circumareolar concentric skin reduction [13–15]. Nevertheless,
here is a high rate of unacceptable or unsatisfactory outcomes.
. Conclusion
The exact mechanism of unilateral gynecomastia formation in
ur case is unclear. The evaluation of unilateral gynecomastia can
herefore be complex. It should begin with a patient’s detailed his-
ory, physical examination and hormonal function test to access
he causes and to exclude systemic or neoplastic diseases. Surgery
n case of idiopathic gynecomastia has assumed a high value in the
herapeutic protocol. In conclusion, the surgical treatment of uni-
ateral gynecomastia requires an individual approach, depending
n the grade of male breast hypertrophy. Based on the presented
ata, true glandular hypertrophy requires a surgical glandular tis-
ue excision and subsequent histological examination, avoiding the
ncological issues. For this reason, in doubtful cases like ours, we
ave performed a subcutaneous mastectomy with totally removed
he gland and setting up an advancement ﬂap of adipose tissue to
revent the adhesion of the nipple to the pectoralis fascia and its
nesthetic depression. Subsequently, liposuction can be used as an






Both father and mother of the young patient, that is the sub-
ect of our study, donated his consensus to scientiﬁc treatment and
ublication of his clinic situation and images. We have obtained
ritten consent from both parents of young patient and that we
an provide this should the Editor ask to see it.
This study was approved by our Internal Ethical Committee (Sec-
nd University Ethical Committee).
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